Why the Elixinol Global (ASX:EXL) share price is getting smoked today

The Elixinol Global Ltd (ASX: EXL) share price is being smashed today, down 14.3%. Here's why this ASX cannabis company is being smoked

| More on:
asx cannabis shares represented by pug dog pointing to blackboard with cannabis info on it

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Elixinol Global Ltd (ASX: EXL) shares are plummeting today, going for just 18.5 cents a share at the time of writing, down 11.09%. The Elixinol share price closed at 21 cents on Friday and opened at 19 cents this morning before dropping to its current level.

At this share price, Elixinol is just 4 cents away from its all-time low of 14 cents a share, and a whopping 87% from its 52-week high. Since the start of 2020 alone, the company's shares are down 63%.

So what's going on here for the hemp products producer?

Why the Elixinol share price is going up in smoke

Today's share price plunge appears to be connected to an ASX market announcement the company made this morning before market open. In this announcement, Elixinol told investors that an agreement it has with another company by the name of Pet Releaf has been terminated.

Elixinol and Pet Releaf have been in a manufacturing and supply arrangement since August 2019. Under this agreement, the two companies would be "long-term partners".

But according to Elixinol:

The contributions from the Agreement have not been material to Elixinol Global's operations and given the global COVID-19 pandemic has created challenging trading conditions for the industry, the parties agreed to formally terminate the Agreement on 18 December 2020 [US Pacific Standard Time] with a mutual release.

A contributing factor to this breakdown was also a shift in focus for Elixinol. The company stated that:

Elixinol entered into the Agreement with a strategic view at that time of Pet Releaf being a long-term partner of Elixinol. Since that time, Elixinol Global has revised its commercial strategy by focusing on the distribution of higher margin Elixinol-branded products, rather than supporting private labelled products to which the Agreement relates.

However, Elixinol assured investors it will continue to "focus on the strong relationship with Pet Releaf". It notes that Elixinol still maintains a 25% equity interest in Pet Releaf. It stated, "the Company continues to look forward to supporting Pet Releaf's strategic focus on increased product offerings and distribution of high quality hemp-derived CBD pet products in the market".

Investors light up SPP

Elixinol has also made a separate announcement to the ASX today regarding its recent share purchase plan (SPP). Last week, Elixinol told investors its SPP had been heavily oversubscribed. Applications totalled $27.2 million, well over the initial $2 million expected. As a result, the company expanded the SPP size by an additional $12.3 million.

Today's announcement confirms management's belief that the company is well capitalised as a result of the SPP. But the "strong third quarter" the company has recently had will not be spilling over. Elixinol included some remarks from its chief executive officer Mark Horn on the matter:

The fourth quarter certainly is not the quarter that we expected to have… simply because COVID has had a significant impact on our businesses in the UK and Europe. We had more head winds than we expected, so I certainly see that the Q4 quarter is for us one of the more challenging ones compared to the previous quarter. But the reality is that we are really well positioned given that we are a wellness product with great distribution and new growth catalysts.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares finished the trading week on a high this Friday.

Read more »

A businessman stacks building blocks.
Technology Shares

6% gain! What's up with Block shares today?

Block shares are up more than 34% since 2 May.

Read more »

Broker looking at the share price.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why ARB, Block, Mayne Pharma, and Paladin Energy shares are charging higher today

These shares are having a strong finish to the week. But why?

Read more »

A woman puts her hands up as she smashes and breaks through a glass ceiling.
Share Gainers

How these 5 ASX 200 stocks are smashing the benchmark this week

These fives ASX 200 stocks have made some very happy shareholders this week. Here’s how.

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Catalyst Metals, Duratec, Nufarm, and Rio Tinto shares are dropping today

These shares are ending the week in the red. But why?

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

After its strategy day, what does Macquarie think Wesfarmers shares are worth?

Let's see what the broker is saying about this blue chip.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Technology Shares

After surging 13% yesterday, are TechnologyOne shares a buy, hold or sell according to Macquarie?

Valuations matter when investing, and Macquarie feels no different.

Read more »